INTECH Investment Management’s Praxis Precision Medicines PRAX Stock Holding History

INTECH Investment Management’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88M	Sell	5,612 -1,365	-20%	-$432K	0.02%	741
2026 Q1	$2.25M	Sell	6,977 -1,757	-20%	-$544K	0.02%	648
2025 Q4	$2.57M	Buy	8,734 +980	+13%	+$183K	0.02%	626
2025 Q3	$411K	Sell	7,754 -965	-11%	-$46.8K	﹤0.01%	1672
2025 Q2	$367K	Sell	8,719 -79	-0.9%	-$3.01K	﹤0.01%	1769
2025 Q1	$333K	Buy	8,798 +2,460	+39%	+$154K	﹤0.01%	1824
2024 Q4	$488K	Buy	6,338 +2,567	+68%	+$186K	﹤0.01%	1581
2024 Q3	$217K	Buy	+3,771	New	+$204K	﹤0.01%	1683

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

INTECH Investment Management's PRAX Position: Q2 2026 in Review

INTECH Investment Management reduced its Praxis Precision Medicines (PRAX) stake by 20% in Q2 2026, selling an estimated $432K and leaving 5,612 shares worth $1.88M. The position accounts for 0.02% of the portfolio, ranked #741.

INTECH Investment Management first reported a position in PRAX in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.57M in Q4 2025. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

INTECH Investment Management held 5,612 shares of Praxis Precision Medicines worth $1.88M as of Q2 2026.
INTECH Investment Management sold 1,365 Praxis Precision Medicines shares in Q2 2026, an estimated $432K.
Praxis Precision Medicines made up 0.02% of INTECH Investment Management's portfolio in Q2 2026, its #741 holding.
INTECH Investment Management first reported a position in Praxis Precision Medicines in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Praxis Precision Medicines position peaked at $2.57M in Q4 2025.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.